Medical imaging is pivotal in clinical trials for gastric cancer, where precise staging and response evaluation are essential. Imaging technologies like CT, MRI, and PET are integrated into clinical trials, typically using Response Evaluation Criteria in Solid Tumors (RECIST). These… Read More
The assessment of peritoneal metastasis in ovarian cancer is a critical challenge in clinical trials. Inaccurate evaluations can lead to significant discrepancies in treatment responses and patient management. Recent discussions, including insights from Dr. M. Sharma and colleagues at ECR25,… Read More
In the rapidly evolving landscape of clinical trials, maintaining data integrity and minimizing bias while performing BICR (Blinded Independent Central Review) is paramount. The automation of reviewer performance monitoring through advanced platforms, complemented by artificial intelligence (AI), is revolutionizing the… Read More
Prostate cancer is a significant health concern for men, being the most prevalent non-dermatologic cancer and the second leading cause of cancer-related deaths. Advances in imaging, particularly positron emission tomography (PET), along with radioligand therapy (RLT) using specific tracers, are… Read More
Imaging plays a crucial role in pancreatic cancer clinical trials, particularly in the early diagnosis, monitoring, and treatment response evaluation. Often referred to as the "Silent Killer," it is a highly aggressive malignancy that often presents asymptomatically in its early… Read More
Featured Webinar:
Radiologic Analysis of COVID-19 Infection
June 23, 2020
